Invention Grant
- Patent Title: Cyclic di-nucleotide compounds as sting agonists
-
Application No.: US16771814Application Date: 2018-12-17
-
Publication No.: US11685761B2Publication Date: 2023-06-27
- Inventor: Brian M. Andresen , Frank Bennett , Wonsuk Chang , Matthew Lloyd Childers , Jared N. Cumming , Jongwon Lim , Min Lu , Benjamin Wesley Trotter , Wen-Lian Wu
- Applicant: Merck Sharp & Dohme Corp. , Brian M. Andresen , Frank Bennett , Wonsuk Chang , Matthew Lloyd Childers , Jared N. Cumming , Jongwon Lim , Min Lu , Benjamin Wesley Trotter , Wen-Lian Wu
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme LLC
- Current Assignee: Merck Sharp & Dohme LLC
- Current Assignee Address: US NJ Rahway
- Agent Julie M. Lake; Catherine D. Fitch
- International Application: PCT/US2018/065902 2018.12.17
- International Announcement: WO2019/125974A 2019.06.27
- Date entered country: 2020-06-11
- Main IPC: C07H21/00
- IPC: C07H21/00 ; A61P37/04 ; C07H21/02 ; A61K31/7084 ; C07H21/04

Abstract:
A class of polycyclic compounds of general formula (I), wherein Base1, Base2, Y, Za, Xa, Xa1, Xb, Xb1, Xc, Xc1, Xd, Xd1, R1, R1a, R2, R2a, R3, R4, R4a, R5, R6, R6a, R7, R7a, R8, R8a, and R9 are defined herein, that may be useful as inductors of type I interferon production, specifically as STING active agents, are provided. Also provided are processes for the synthesis and use of compounds.
Public/Granted literature
- US20210206796A1 CYCLIC DI-NUCLEOTIDE COMPOUNDS AS STING AGONISTS Public/Granted day:2021-07-08
Information query